Mandate

Vinge advises Alfa Laval on its takeover bid for Neles

Alfa Laval AB (publ) has announced a recommended public cash offer to the shareholders of Neles Corporation.

The offer values all shares in Neles at approximately EUR 1.727 billion.

The Vinge team includes Erik Sjöman, Linnéa Sellström, Henrik Ossborn, Fabian Ekeblad, Fredrik Christiansson, Mattias Schömer and Maria Schultzberg.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025